Saw palmetto and Decadron drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Saw palmetto and Decadron. Common interactions include blood creatine phosphokinase increased among females and nausea among males.
The phase IV clinical study analyzes what interactions people who take Saw palmetto and Decadron have. It is created by eHealthMe based on reports of 53 people who take Saw palmetto and Decadron from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53 people who take Saw palmetto and Decadron together, and have interactions are studied.
What is Saw palmetto?
Saw palmetto has active ingredients of saw palmetto. It is often used in prostate examination abnormal. eHealthMe is studying from 3,374 Saw palmetto users for its effectiveness, alternative drugs and more.
What is Decadron?
Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 45,089 Decadron users for its effectiveness, alternative drugs and more.
Number of Saw palmetto and Decadron reports submitted per year:
Common Saw Palmetto and Decadron drug interactions by gender *:
- Blood creatine phosphokinase increased
- Blood glucose increased
- Chest pain
- Renal failure
- Head injury
- Neuropathy peripheral
- Right ventricular failure
- Weight increased
- Oedema peripheral
- Septic shock
Common Saw Palmetto and Decadron drug interactions by age *:
- Neuropathy peripheral
- Oral herpes
- Poor dental condition
- Road traffic accident
- Oedema peripheral
- Septic shock
- Streptococcal sepsis
Common conditions people have *:
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 9 people, 16.98%
- Pathological Fracture (broken bone caused by disease): 7 people, 13.21%
- Bone Erosion: 7 people, 13.21%
- Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 7 people, 13.21%
- Pain: 5 people, 9.43%
- High Blood Pressure: 3 people, 5.66%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 5.66%
- Bipolar Disorder (mood disorder): 3 people, 5.66%
* Approximation only. Some reports may have incomplete information.
Do you take Saw palmetto and Decadron?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Alternative drugs to, pros and cons of the 2 drugs:
Common Saw palmetto and Decadron interactions:
Browse all drug interactions of Saw palmetto and Decadron:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Saw palmetto interactions:
Browse all interactions between Saw palmetto and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Decadron interactions:
Browse all interactions between Decadron and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on saw palmetto and dexamethasone (the active ingredients of Saw palmetto and Decadron, respectively), and Saw palmetto and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Saw palmetto and Decadron.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zerit and Excitability - 25 seconds ago
- Detrol La and Mouth Ulcers - 40 seconds ago
- Mirapex and Cytoxan drug interaction - 42 seconds ago
- Crohn'S Disease and Uterine Mass - 44 seconds ago
- Latanoprost and Zytiga drug interaction - 54 seconds ago
- Candesartan Cilexetil vs. Guanfacine Hydrochloride - a minute ago
- Chlorzoxazone and Gastric Ulcer - a minute ago
- Doxil and Duricef drug interaction - a minute ago
- Gastric Ulcer and drugs of ingredients of desmopressin acetate - a minute ago
- Trilipix and Quetiapine Fumarate drug interaction - 2 minutes ago